1. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy. Issue 11 (November 2015) Authors: Koren, Michael J.; Kereiakes, Dean; Pourfarzib, Ray; Winegar, Deborah; Banerjee, Poulabi; Hamon, Sara; Hanotin, Corinne; McKenney, James M. Journal: Journal of the American Heart Association Issue: Volume 4:Issue 11(2015) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia. Issue 6 (6th August 2019) Authors: Ahmad, Zahid; Banerjee, Poulabi; Hamon, Sara; Chan, Kuo-Chen; Bouzelmat, Aurelie; Sasiela, William J.; Pordy, Robert; Mellis, Scott; Dansky, Hayes; Gipe, Daniel A.; Dunbar, Richard L. Journal: Circulation Issue: Volume 140:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial. (8th September 2021) Authors: Boyapati, Anita; Wipperman, Matthew F; Ehmann, Peter J; Hamon, Sara; Lederer, David J; Waldron, Alpana; Flanagan, John J; Karayusuf, Elif; Bhore, Rafia; Nivens, Michael C; Hamilton, Jennifer D; Sumner, Giane; Sivapalasingam, Sumathi Journal: Journal of infectious diseases Issue: Volume 224:Number 11(2021) Page Start: 1830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of ethnicity, gender and drug use history on achieving high rates of affirmative informed consent for genetics research: impact of sharing with a national repository. Issue 6 (25th January 2011) Authors: Ray, Brenda; Jackson, Colin; Ducat, Elizabeth; Ho, Ann; Hamon, Sara; Kreek, Mary Jeanne Journal: Journal of medical ethics Issue: Volume 37:Issue 6(2011) Page Start: 374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy. Issue 11 (19th November 2015) Authors: Koren, Michael J.; Kereiakes, Dean; Pourfarzib, Ray; Winegar, Deborah; Banerjee, Poulabi; Hamon, Sara; Hanotin, Corinne; McKenney, James M. Journal: Journal of the American Heart Association Issue: Volume 4:Issue 11(2015) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. (25th July 2011) Authors: Levran, Orna; Peles, Einat; Hamon, Sara; Randesi, Matthew; Adelson, Miriam; Kreek, Mary Jeanne Journal: Addiction biology Issue: Volume 18:Number 4(2013:Jul.) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 340 Dupilumab treatment of children with moderate-to-severe atopic dermatitis increases bone alkaline phosphatase, a marker of bone mineralization. (25th January 2023) Authors: Irvine, Alan D; Paller, Amy S; Hamon, Sara; Horowitz, Julie; Farrell, Annamaria; Hatsell, Sarah; Marco, Ainara Rodríguez; Bansal, Ashish; Chen, Zhen; Cyr, Sonya L Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness. (21st November 2022) Authors: Lind, Margaret L; Copin, Richard; McCarthy, Shane; Coppi, Andreas; Warner, Fred; Ferguson, David; Duckwall, Chelsea; Borg, Ryan; Muenker, M Catherine; Overton, John; Hamon, Sara; Zhou, Anbo; Cummings, Derek A T; Ko, Albert I; Hamilton, Jennifer D; Schulz, Wade L; Hitchings, Matt D T Journal: Journal of infectious diseases Issue: Volume 227:Number 5(2023) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. (December 2015) Authors: Hopkins, Paul N.; Defesche, Joep; Fouchier, Sigrid W.; Bruckert, Eric; Luc, Gérald; Cariou, Bertrand; Sjouke, Barbara; Leren, Trond P.; Harada-Shiba, Mariko; Mabuchi, Hiroshi; Rabès, Jean-Pierre; Carrié, Alain; van Heyningen, Charles; Carreau, Valérie; Farnier, Michel; Teoh, Yee P.; Bourbon, Mafa... Journal: Circulation Issue: Volume 8:Number 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo. Issue 1 (December 2016) Authors: Toth, Peter; Hamon, Sara; Jones, Steven; Martin, Seth; Joshi, Parag; Kulkarni, Krishnaji; Banerjee, Poulabi; Hanotin, Corinne; Roth, Eli; McKenney, James Journal: Lipids in health and disease Issue: Volume 15:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗